Fudan University: Sarcoma trials

The registry lists 14 Sarcoma studies with Fudan University as lead sponsor. 7 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 12Phase 3 1No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Multicenter, Single-arm, Prospective Phase II Clinical Study of Epalrotokewali Combined With Eribulin, Anlotinib, and Radiotherapy for the Treatment of Patients With Advanced Soft Tissue Sarcoma.Not yet recruitingNCT07205185Phase 2
• IO Combined With AI as First-line Treatment for Patients With Soft Tissue Sarcoma(TAIS)RecruitingNCT06849986Phase 2
• A Prospective, Randomized, Controlled Clinical Study on the Prevention of Chemotherapy Related Myelosuppression in Patients with Ewing's Sarcoma Using TrilaciclibRecruitingNCT06699472Phase 2
• First-line Treatment of Advanced/unresectable DDLPSNot yet recruitingNCT06694324Phase 2
• Ivonescimab in the Treatment of Multiple Advanced TumorsRecruitingNCT06683846Phase 2
• A Study of Surufatinib in the Treatment of Advanced Soft Tissue SarcomaNot yet recruitingNCT06110650Not applicable
• The Combination of Radiotherapy，Surufatinib and Sintilimab in High-Risk Localized Soft Tissue SarcomaRecruitingNCT05839275Phase 1/2
• Fruquintinib in the Treatment of Soft Tissue SarcomaStatus unknownNCT05142631Phase 2
• The Combination of Sintilimab and AI (Doxorubicin, ADM/Ifosfamide, IFO) for the First Line Treatment of Select Type of Metastatic/Unresectable Soft Tissue SarcomaStatus unknownNCT04356872Phase 2
• Efficacy and Safety of Anlotinib in Adjuvant Therapy for High-grade Soft Tissue SarcomaCompletedNCT03951571Phase 2
• PLD and IFO As First-line Treatment for Patients With Advanced or Metastatic STSStatus unknownNCT03268772Phase 2
• Role of Barrier Resection in Local Control for Extremity Recurrent Soft Tissue SarcomasStatus unknownNCT02120768Phase 3
• Gemcitabine,Vincristine and Cisplatin as Second Line Combination Therapy in Patients With SarcomaStatus unknownNCT01192633Phase 2
• Study on VCD/IE in the Patients With Ewing's Sarcoma Family of Tumors (ESFT)TerminatedNCT00568464Phase 2